Kiromic BioPharma, Inc is a biotechnology business based in the US. Kiromic BioPharma shares (KRBP) are listed on the NASDAQ and all prices are listed in US Dollars. Kiromic BioPharma employs 19 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Kiromic BioPharma
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – KRBP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Kiromic BioPharma stock price (NASDAQ: KRBP)Use our graph to track the performance of KRBP stocks over time.
Kiromic BioPharma shares at a glance
|Latest market close||$8.12|
|52-week range||$2.87 - $12.11|
|50-day moving average||$6.80|
|200-day moving average||$8.51|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
Buy Kiromic BioPharma shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Kiromic BioPharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Kiromic BioPharma price performance over time
|1 week (2021-07-19)||N/A|
|1 month (2021-06-30)||68.81%|
|3 months (2021-04-30)||-3.91%|
|6 months (2021-01-26)||N/A|
|1 year (2020-07-26)||N/A|
|2 years (2019-07-26)||N/A|
|3 years (2018-07-26)||N/A|
|5 years (2016-07-26)||N/A|
Kiromic BioPharma financials
|Gross profit TTM||$0|
|Return on assets TTM||-182.1%|
|Return on equity TTM||-352.34%|
|Market capitalisation||$49.2 million|
TTM: trailing 12 months
Shorting Kiromic BioPharma shares
There are currently 178,676 Kiromic BioPharma shares held short by investors – that's known as Kiromic BioPharma's "short interest". This figure is 392.5% up from 36,277 last month.
There are a few different ways that this level of interest in shorting Kiromic BioPharma shares can be evaluated.
Kiromic BioPharma's "short interest ratio" (SIR)
Kiromic BioPharma's "short interest ratio" (SIR) is the quantity of Kiromic BioPharma shares currently shorted divided by the average quantity of Kiromic BioPharma shares traded daily (recently around 232046.75324675). Kiromic BioPharma's SIR currently stands at 0.77. In other words for every 100,000 Kiromic BioPharma shares traded daily on the market, roughly 770 shares are currently held short.
To gain some more context, you can compare Kiromic BioPharma's short interest ratio against those of similar companies.
However Kiromic BioPharma's short interest can also be evaluated against the total number of Kiromic BioPharma shares, or, against the total number of tradable Kiromic BioPharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Kiromic BioPharma's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Kiromic BioPharma shares in existence, roughly 20 shares are currently held short) or 0.0372% of the tradable shares (for every 100,000 tradable Kiromic BioPharma shares, roughly 37 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Kiromic BioPharma.
Find out more about how you can short Kiromic BioPharma stock.
Kiromic BioPharma share dividends
We're not expecting Kiromic BioPharma to pay a dividend over the next 12 months.
You may also wish to consider:
- Bio-Techne Corporation (TECH.US) (0.28% forward annual dividend yield)
Kiromic BioPharma overview
Kiromic BioPharma, Inc. , a target discovery and gene editing company, focuses on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1; and chimeric gamma delta PD1 T cell switch receptor therapy. It has license agreements with Mercer University; CGA 369 Intellectual Holdings, Inc. ; and Longwood University, as well as research and development collaboration agreements with Molipharma, S. R. L.
Stocks similar to Kiromic BioPharma
Kiromic BioPharma in the news
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kiromic BioPharma, Inc. - KRBP
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
62 Biggest Movers From Yesterday
Frequently asked questionsWhat percentage of Kiromic BioPharma is owned by insiders or institutions?
Currently 32.038% of Kiromic BioPharma shares are held by insiders and 9.211% by institutions. How many people work for Kiromic BioPharma?
Latest data suggests 19 work at Kiromic BioPharma. When does the fiscal year end for Kiromic BioPharma?
Kiromic BioPharma's fiscal year ends in December. Where is Kiromic BioPharma based?
Kiromic BioPharma's address is: 7707 Fannin, Houston, TX, United States, 77054 What is Kiromic BioPharma's ISIN number?
Kiromic BioPharma's international securities identification number is: US4976341051
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert